FDA to weigh easing limits on unproven peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? What are peptides? The treatments promising weight loss and better skin, explained Vox Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law